Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001387131-12-001213
Filing Date
2012-04-17
Accepted
2012-04-17 16:41:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D milligan-sc13d_041612.htm SC 13D 77164
  Complete submission text file 0001387131-12-001213.txt   78734
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 516-961-1911
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-32384 | Film No.: 12764107
SIC: 2834 Pharmaceutical Preparations

Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address
Milligan John C.K. IV (Filed by) CIK: 0001532230 (see all company filings)

Type: SC 13D